New Nobel Laureates Speak Out For Increased Research Funding

LUCKY STARS: Harold Kroto was studying carbon clusters when he and coworkers discovered buckyballs. Like many of their predecessors, the winners of the 1996 Nobel Prizes in science have found that the media attention accompanying the honor provides an excellent opportunity to speak out on behalf of important causes. Last month, five of the eight newly named science laureates used their "bully pulpit" to voice concerns about research funding at a National Science Foundation news conference. Th

Written bySteven Benowitz
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Harold Kroto
LUCKY STARS: Harold Kroto was studying carbon clusters when he and coworkers discovered buckyballs.
Like many of their predecessors, the winners of the 1996 Nobel Prizes in science have found that the media attention accompanying the honor provides an excellent opportunity to speak out on behalf of important causes. Last month, five of the eight newly named science laureates used their "bully pulpit" to voice concerns about research funding at a National Science Foundation news conference. The five winners-all Americans who have been funded by NSF-expressed fears that the funding sources that made their prize-winning research possible are drying up.

The October 17 conference occurred days after the Nobel recipients were announced. In chemistry, three researchers were honored for discoveries that helped establish a new genre of carbon-based materials known as buckminsterfullerenes, or buckyballs. Two immunologists were cited for revealing how T cells methodically attack virus infected cells. Three physicists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies